Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China · Delayed Price · Currency is CNY

13.98

+0.79 (5.99%)

Aug 4, 2026, 3:00 PM CST

-12.57% (1Y)

Market Cap	5.88B -12.6%
Revenue (ttm)	699.33M +33.8%
Net Income	-27.51M
EPS	-0.07
Shares Out	420.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,424,051
Open	13.34
Previous Close	13.19
Day's Range	13.20 - 14.09
52-Week Range	11.40 - 22.55
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. It offers anti-HIV drugs and human-derived proteins. The company also provides anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2009

Employees 735

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688488

Full Company Profile

Financial Performance

In 2025, SHA:688488's revenue was 719.17 million, an increase of 72.13% compared to the previous year's 417.80 million. Losses were -19.53 million, -86.17% less than in 2024.

Financial Statements